An artificial intelligence (AI) model may help predict clinical outcomes at the time of laparoscopic assessment for advanced high-grade serous ovarian cancer (HGSOC), according to a study presented at the Society of Gynecologic ...
Mar 25, 2022
0
10
Researchers, led by Pennington Biomedical Research Center's Dr. Justin Brown, have found that physical activity can prevent, and not just delay, cancer recurrence in patients previously treated for colon cancer.
Mar 21, 2023
0
2
Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, according to a new study ...
Oct 27, 2021
0
29
A study conducted in rats suggests that taking vitamin C may help to counteract the muscle atrophy that is a common side effect of the chemotherapy drug doxorubicin. Although clinical studies would be needed to determine ...
Apr 4, 2022
0
2
A clinical trial led by clinicians at Georgetown Lombardi Comprehensive Cancer Center showed a remarkable 20 percent advantage in the two-year overall survival rate for people with advanced melanoma who first received immunotherapy ...
Sep 27, 2022
0
21
Initial results of NRG-LU001 indicate that, although the diabetes agent metformin was well-tolerated by patients, the agent has not clearly improved progression-free survival (PFS) or overall survival (OS) for trial participants ...
Jun 1, 2019
0
4
A UCLA-led research team has pinpointed a three-drug combination that could prove to be an effective new therapy for people with a specific type of advanced melanoma.
Jun 6, 2019
0
135
(HealthDay)—The U.S. Food and Drug Administration has granted supplemental approval to Calquence (acalabrutinib) for treatment of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), the agency announced ...
Nov 22, 2019
0
0
The Alliance for Clinical Trials in Oncology today announced that an independent Data and Safety Monitoring Board (DSMB) determined that the phase III CABINET (A021602) pivotal trial met its primary endpoint at an interim ...
Aug 24, 2023
0
19
A new treatment that may extend survival for patients with advanced biliary tract cancers—who typically face a grim outlook with average survival of less than a year—is being studied by a University of Arizona Cancer ...
Jul 30, 2019
0
43
